Case report: Subclinical verminous pneumonia and high ambient temperatures had severe impact on the anesthesia of semi-domesticated Eurasian tundra reindeer (Rangifer tarandus tarandus) with medetomidine-ketamine by Tryland, Morten et al.
CASE REPORT
published: 24 February 2021
doi: 10.3389/fvets.2021.606323















This article was submitted to
Zoological Medicine,
a section of the journal
Frontiers in Veterinary Science
Received: 14 September 2020
Accepted: 19 January 2021
Published: 24 February 2021
Citation:
Tryland M, Josefsen TD, Sánchez
Romano J, Marcin N, Mørk T and
Arnemo JM (2021) Case Report:
Subclinical Verminous Pneumonia and
High Ambient Temperatures Had
Severe Impact on the Anesthesia of
Semi-domesticated Eurasian Tundra
Reindeer (Rangifer tarandus tarandus)
With Medetomidine–Ketamine.
Front. Vet. Sci. 8:606323.
doi: 10.3389/fvets.2021.606323
Case Report: Subclinical Verminous
Pneumonia and High Ambient
Temperatures Had Severe Impact on
the Anesthesia of Semi-domesticated
Eurasian Tundra Reindeer (Rangifer
tarandus tarandus) With
Medetomidine–Ketamine
Morten Tryland 1*, Terje D. Josefsen 2,3, Javier Sánchez Romano 1, Nina Marcin 1,
Torill Mørk 2 and Jon M. Arnemo 4,5
1 Arctic Infection Biology, Department of Arctic and Marine Biology, UiT The Arctic University of Norway, Tromsø, Norway,
2 Section for Research in Food Safety and Animal Health, Norwegian Veterinary Institute, Tromsø, Norway, 3 Faculty of
Biosciences and Aquaculture, Nord University, Bodø, Norway, 4Department of Forestry and Wildlife Management, Inland
Norway University of Applied Sciences, Evenstad, Koppang, Norway, 5Department of Wildlife, Fish and Environmental
Studies, Swedish University of Agricultural Sciences, Umeå, Sweden
Semidomesticated Eurasian tundra reindeer (Rangifer tarandus tarandus, n = 21) were
scheduled twice for chemical immobilization with medetomidine–ketamine as part of
a scientific experiment in June 2014. During the first round of immobilizations, seven
animals developed severe respiratory depression (RD). Three individuals died, and 4
recovered. The ambient temperature during the 2 days of immobilization (June 3 and
4) was high (mean 13.9–17.6◦C) compared to the normal mean temperature for these 2
days (7–8◦C) based on statistical records. During the second round of immobilizations,
using the same anesthetic protocol for the remaining animals as in the first round but
conducted under cooler conditions (mean 6.6◦C for the period June 9–18), no signs of
RD were observed. Clinical and pathological investigations indicated that the animals
suffered from circulatory changes possibly caused by high ambient temperatures and
granulomatous interstitial pneumonia due to Elaphostrongylus rangiferi larvae. These
conditions, together with the cardiovascular effects of medetomidine, were likely causes
of RD and the fatal outcome. We conclude that chemical immobilization of reindeer with
medetomidine–ketamine should be avoided in May–June due to the potential risk when
animals partly in winter coats encounter rising ambient temperatures and usually have
parasites developing in their airways.
Keywords: Alfa-2 agonist, atipamezole, chemical immobilization, circulation, ketamine, medetomidine, parasite,
rangifer (reindeer/caribou)
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BACKGROUND
A combination of medetomidine and ketamine is commonly
used for chemical immobilization of reindeer and caribou
(Rangifer tarandus ssp.) and has been the recommended
anesthetic drug combination for Eurasian tundra reindeer
(Rangifer tarandus tarandus) for more than 20 years (1, 2).
Medetomidine, a potent alpha-2 adrenoceptor agonist,
has sedative, analgesic, and muscle relaxing properties,
whereas ketamine is a dissociative anesthetic drug (3). In
combination, medetomidine–ketamine induces dose-dependent
immobilization or anesthesia. A commonly encountered adverse
effect of medetomidine–ketamine in reindeer is respiratory
depression (RD), with subsequent hypoxemia and hypoxia
(2). However, we are not aware of any studies reporting
severe adverse effects or mortalities in adult reindeer during
immobilization with medetomidine–ketamine.
Here, we report high rates of severe morbidity and mortality
due to RD in reindeer immobilized with recommended doses
of medetomidine–ketamine and discuss possible causes and risk




One-year-old semidomesticated reindeer (n = 21), 5 non-
pregnant females and 16 males, were selected for an experimental
study and brought from a mountain pasture to a corral [for
details, see Tryland et al. (4)]. Body condition generally increased
during the habituation period (May 6–June 2, 2014). Mean body
mass at the time of immobilization (weighing of chemically
immobilized animals) was 48.8 kg (SD 6.5, range 32–59). Based
on behavior and observations during the habituation period, all
animals were apparently healthy, although transient coughing
(days and weeks before immobilization) was noted for 13
animals, but most severe (>1–2 days) for animals R11, R12,
and R14, which all experienced RD and succumbed from
anesthesia [respiratory depression with fatal outcome (RDF)].
Some coughing was also noted for animals R1, R6, and R19,
which developed severe RD during anesthesia, and for six of the
14 remaining animals, in which RD was not observed.
Chemical Immobilization
Animals were chemically immobilized by dart injection from
∼11 to 12m using a CO2-powered rifle (JM Special, Dan-Inject
ApS, Børkop, Denmark), 3-ml plastic syringes, and 2 × 30mm
barbed needles with side-ports (Dan-Inject ApS). All animals
were darted in the large muscles of the lateral thigh while calmly
grazing in a corral. A combination of medetomidine (Zalopine
10 mg/ml, Orion Corporation Animal Health, Espoo, Finland)
and ketamine (Ketalar 50 mg/ml, Pfizer AS, Oslo, Norway) was
used. Initial dose ranges were 3.5–9.0mg medetomidine and
Abbreviations: RD, respiratory depression; RDF, respiratory depression with fatal
outcome; RDR, respiratory depression, recovered; RD–, no sign of respiratory
depression; SpO2, oxygen saturation in blood; TBD, time body down; THD, time
head down; IKC, infectious keratoconjunctivitis.
17.5–45.0mg ketamine per animal, with a fixed ratio of 1:5
(mg:mg) for medetomidine:ketamine. Body mass was not known
prior to immobilization. Doses in the high range were used in
the first 5 animals based on Ryeng et al. (1), as recommended
for darting. Two of these animals developed signs of RD during
anesthesia, and subsequent doses were adjusted to lower doses,
as recommended for hand injection (1). Since RD continued to
occur in a few animals, doses were further reduced (Table 1).
Immobilized animals were weighed in a tarpaulin using a
spring scale. The mean drug doses were 0.116 (SD 0.051; range
0.063–0.203) mg/kg medetomidine and 0.578 (SD 0.256; range
0.313–1.014) mg/kg ketamine. The mean time from darting to
the animal laid down on the ground [time body down (TBD)]
was 4min 5 s (SD 1min 58 s, range 1min 35 s−9min 31 s). The
mean time from darting to when the head was on the ground
was 5min 21 s (SD 1min 56 s, range 2min 46 s−9min 50 s).
Animals were maintained in sternal recumbency. Observations
of clinical parameters were recorded at ∼5, 15, and 30min
after darting, before the animals were placed in smaller corrals
for each experimental group. Rectal temperature was measured
with a digital thermometer. Pulse rate and peripheral oxygen
hemoglobin saturation were measured by pulse oximetry (SpO2;
Masimo Rad 5v Pulsoksimeter; Infiniti Medical, Drammen,
Norway), with the sensor applied to the tongue. Respiratory rate
was recorded by observing thoracic wall movements and using
a stopwatch.
The first round of immobilization was conducted on June
3–4, 2014, under sunny conditions and with ambient mean
temperatures of 13.9–17.6◦C, with maximum temperatures of
17.3 and 21.8◦C for June 3 and 4, respectively (Figure 1).
Atipamezole (Antisedan vet. 5 mg/ml; Orion Corporation
Animal Health) at 5 mg/mg medetomidine was administered
intramuscularly (i.m.) for reversal 16–36min (mean 31min)
after darting. Three animals died during the first round of
immobilization. For the remaining animals (n = 18), the mean
times from administration of atipamezole to lifting of the head
and standing were 7min 26 s and 8min 23 s, respectively.
The second round of immobilization was conducted on
June 9–18, 2014, under a mean ambient temperature of
6.6◦C, with a maximum temperature of 11.5◦C (Figure 1) and
with precipitation as snow. Due to the termination of the
experiment, the second round of immobilization was followed
by euthanasia of the remaining animals (4). The second round
of chemical immobilization was carried out with the same
drugs and doses as administered for each individual during the
first round.
Clinical Signs and Treatment
During the first round of immobilization, seven of 21 animals
showed signs of RD with increased respiratory rate, labored
breathing, or apnea, of which 3 animals died. Animal R14 laid
down and also laid her head down 3min 27 s after injection and
stopped breathing before we managed to measure respiratory
rate. Animals R11 and R12 laid down 3min 46 s and 3min
1 s after injection, respectively, but displayed RD and stopped
breathing shortly after. The 3 animals (R11, R12, and R14)
were treated with a ready-to-use i.m. injection of atipamezole
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TABLE 1 | Individual recording of the seven animals that experienced respiratory depression (RDF, respiratory depression fatal; RDR, respiratory depression, recovered)
compared to the mean for the remaining 14 animals (RD–, no respiratory depression; mean values, n = 14, bottom row): body mass, drug doses, time from


























RDF 11 M 50 0.08 + 0.40 3:46 5:53 75 71 20 39.4
12 M 47 0.07 + 0.37 3:01 5:18 83 75 40 39.5
14 F 43 0.17 + 0.87 3:27 3:27 62 65 – 39.8
Mean RDF – 47 0.11 + 0.55 3:25 4:53 73 70 30 39.6
RDR 1 M 50 0.08 + 0.40 2:29 (3:18) 3:48 (5:19) 68 (78) 63 (53) 52 (16) 38.7 (39.1)
6 M 46 0.20 + 0.98 6:04 (0:45) 6:10 (3:10) 45 (84) 90 (91) 24 (40) 39.4 (39.6)
8 M 46 0.20 + 0.98 6:05 (0:48) 6:17 (1:08) 77 (62) 79 (81) 8 (24) 39.4 (40.5)
19 M 46 0.09 + 0.44 3:16 (3:16) 3:48 (4:18) 61 (80) 76 (70) 80 (NR) 39.5 (NR)





50 0.11 + 0.53 4:07 (4:28) 5:33 (8:15) 58 (48) 82 (86) 28 (43) 39.1 (40.1)
Numbers in parentheses are recordings during the second round of immobilization; same animals, drugs, and doses, but under significantly lower ambient temperature.
*Animals chemically immobilized twice (RDR and RD–) were given the same individual dose both times.
**Heart rate, SpO2, respiratory rate, and temperature are presented as mean values calculated from 3 measurements during the immobilization (prior to antidote injection or euthanasia).
NR, not recorded.
FIGURE 1 | The mean ambient temperature in Tromsø (Holt Meteorological Station; lat. 69.6538, long. 18.9095; Norwegian Meteorological Institute) for June 2014 is
shown as a red line. The temperature is measured 100m above sea level and ∼0.5 km from the animal facility. Maximum and minimum temperatures are indicated
with pink boxes. Normal temperature is defined as the mean for the reference period 1961–1990. The first round of chemical immobilization (medetomidine–ketamine)
of Eurasian tundra reindeer (Rangifer tarandus tarandus) was conducted at sunny conditions and under ambient temperatures well-above mean for the period
(maximum 17.3◦C, mean 13.9◦C for June 3; maximum 21.8◦C, mean 17.6◦C for June 4). The fatal reindeer cases are inserted (R14, R11, R12). In contrast, the
second round of immobilization (June 9–18) was conducted under lower temperatures (maximum 11.5◦C, mean 6.6◦C for the period) and with precipitation as snow.
(dose adjusted to the administered dose of medetomidine for
each animal) and intravenous injection (i.v.) of 100mg of the
respiratory stimulant doxapram (Dopram 20 mg/ml; Boehringer
Ingelheim, Ingelheim am Rhein, Germany). Upon cardiac arrest,
these 3 animals were treated with an intracardiac injection of
adrenaline (Adrenalin 0.1 mg/ml; Takeda AS, Asker, Norway) as
well as cardiac compression. The animals did not respond to any
treatment and died (RDF).
Four additional animals (animals R1, R6, R8, and R19) showed
increased respiratory rate and labored breathing. Animal R1
received half a dose of atipamezole i.m. and recovered. Animal R6
stopped breathing immediately after the dart injection, received
a full dose of atipamezole i.m., and resumed respiration. Animals
R8 and R19 received 100mg doxapram i.v. followed by a full
dose of atipamezole i.m. and recovered [respiratory depression,
recovered (RDR)].
The remaining 14 animals showed no signs of RD [respiratory
depression minus (RD–)] during immobilization. Recordings of
body mass, drug dose, time points for TBD and time head down
(THD), heart rate, SpO2, respiratory rate, and rectal temperature
for the two rounds of immobilization are presented in Table 1.
Hyperthermia, defined as body temperature≥2◦C higher than
normal (2), was not recorded in any of the animals (Table 1). The
recorded rectal temperatures in the RDR and RD– groups when
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comparing the first (RDR 39.3, RD– 39.1) and the second (RDR
39.7, RD– 40.1) immobilization did not indicate higher rectal
temperatures during the first immobilization, conducted during
higher ambient temperatures.
Examination of Carcasses
Respiratory Depression With Fatal Outcome Group
Animals R11, R12, and R14 were subjected to a full necropsy
within 24 h after death, including routine histological
examination of tissues frommyocardium, lung, liver, kidney, and
brain. The animals were all in normal body condition for the time
of year, with no difference when compared to animals in the RDR
and RD– groups. The main gross findings for all 3 RDF animals
were in the thorax. Lungs were diffusely firm and rubbery and
failed to collapse (Figure 2A). The color of the lungs was light
pink, reflecting little blood in lung vessels and capillaries. The
interlobular septa were slightly expanded, indicating moderate
interstitial edema. Trachea was filled with rich amounts of white
or slightly bloodstained viscous foam, oozing out of the mouth
and nostrils post mortem in animal R12. The heart contained
no blood in neither atria nor ventricles. Various amounts of
bloodstained subcutaneous edema were present in the thoracic
inlet (R12 and R14), lower ventral neck (R12), upper part of
the right (R14) or left (R11) shoulder, and in both flanks (R14).
There was hyperemia in cutaneous vessels, most pronounced
in animal R11. Scattered areas of subcutaneous petechiae
were seen in R11 and R12. Histological examination of lung
tissue revealed a multifocal, partly coalescing granulomatous
interstitial pneumonia in all animals, with frequent occurrence of
nematode eggs and developing stages of larvae, morphologically
corresponding to Elaphostrongylus rangiferi (i.e., “brain worm”)
(Figure 2B). The affected lung tissue comprised about 3/4 of the
lung tissue in R12, 2/3 in R14, and 1/3 in R11.
Respiratory Depression, Recovered, and No Sign of
Respiratory Depression Groups
Animals of the RDR group (n = 4) and RD– group (n =
14), chemically immobilized a second time prior to euthanasia
5–13 days after the initial immobilization, were not subjected
to full necropsy. An inspection of body condition and organs
was performed, gross findings were subjected to histological
examination, and the presence of macroparasites was registered.
Diffusely firm and “rubbery lungs” (similar to RDF animals) were
observed in R1 (RDR group) and in R2 and R18 (RD– group).
In the lungs of R8 (RDR group), firm areas, partly as nodules of
0.5–1.5 cm in diameter, were distributed in cranial and caudal
lung lobes on both sides. Histological examination revealed
an acute and subacute purulent pneumonia with multifocal
necrosis. Bacterial cultivation from lesions showed a rich
growth of mixed microbiota, from which Streptococcus suis II
was isolated.
Macroparasites in the Respiratory Tract
A low number (1–7) of throat bot larvae (Cephenemyia trompe)
were detected in two animals from the RDF group and two from
the RD– group. Heavy infection with throat bot larvae was found
FIGURE 2 | Lungs from animal R12, one of 3 Eurasian tundra reindeer
(Rangifer tarandus tarandus) that died during chemical immobilization.
(A) Macroscopic view: Firm rubbery lungs that failed to collapse. Trachea to
the left (opened) is filled with foam (cross). (B) Histology: Multifocal
granulomatous interstitial pneumonia. Developing nematode larvae are visible
in 2 granulomas (arrowheads). Approximately 3 quarters of the lung tissue of
this reindeer was affected similar to the region shown.
in animal R1 (RDR group), with 107 larvae in the nasopharynx
and nasal cavity. Trachea and the main bronchi were opened and
inspected in all animals. The reindeer lungworm (Dictyocaulus
eckerti) was detected in moderate numbers (10–20 worms)
in R2 and R20 (RD– group) but not associated with gross
pathological changes.
DISCUSSION AND CONCLUSIONS
Twenty-one semidomesticated reindeer were anesthetized with
medetomidine–ketamine by remote injection. Seven animals
displayed increased respiratory rate and labored breathing, and
3 of the animals stopped breathing and died. Necropsy revealed
interstitial pneumonia due to E. rangiferi larvae. When the
remaining animals were anesthetized a second round with the
same drugs and individual doses, but under significantly colder
weather conditions, no RD was observed.
When two of the animals initially immobilized with the
recommended doses displayed RD, measures were taken to avoid
complications for the remaining animals. Darting was carried
out after 18:00 at lower ambient temperatures and with lower
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drug doses. Including the first 5 animals that received the full
recommended doses for ground-darting of semidomesticated
reindeer, the administered doses (n = 21) were on average 65%
of the recommended dose for medetomidine–ketamine (1). In
spite of the reduction, two of the 3 last animals to be immobilized
during the first round died. These two individuals received 46%
and 43% of the recommended doses, respectively. To investigate
if the unexpected severe effects in some animals during the
first round of immobilization were associated with the ambient
temperatures, we used the same drugs and doses as administered
for each individual during the first round in the second round,
leaving the temperature difference as the main variable when
comparing the two immobilizations.
Mature throat bot larvae that are ejected through the mouth
or nostrils of reindeer (late April to June and July) by coughing
(5) may cause airway obstruction. Coughing was observed in
several animals during the habituation period, but at the time
of the second round of immobilization, only 1 animal (R1, RDR
group) had a larger number of throat bots. This animal had the
lowest SpO2 values recorded during both rounds of chemical
immobilization (63 and 53%, respectively). Throat bot larvaemay
thus have influenced blood oxygenation but can hardly explain
the RD for other animals hosting only a few larvae.
More importantly, the necropsy findings in the RDF animals
suggested circulatory collapse and pulmonary edema. The lungs
contained little blood. There was no blood in the heart in any
of the 3 RDF animals, which may be due to the conducted
cardiac compressions. The spleens in animals R12 and R14 (RDF
group) were moderately congested, but otherwise the abdominal
organs contained sparse amounts of blood. Thus, the bulk of
blood was distributed peripherally, in skin and subcutaneous
tissues. This may be a cardiovascular response to high ambient
temperatures in order to increase heat loss (6). In animals treated
with medetomidine, blood flow is usually directed to vital organs
and reduced in muscle, fat, and other non-vital tissues (7).
The pulmonary edema that developed in all RDF animals
may also have been conditioned by the parasitic interstitial
pneumonia, as lung inflammation predisposes to edema
formation (8). Whether the use of medetomidine had also
influenced the rapid edema formation is uncertain. In sheep,
dexmedetomidine has been shown to induce pulmonary edema
in healthy animals (9), but similar findings are not reported in
other ruminants.
A prominent pathological finding in all RDF reindeer was a
granulomatous pneumonia due to E. rangiferi larvae. The adult
nematodes live in muscle fasciae and deposit eggs in veins. The
eggs are carried to the lungs where they develop to first-stage
larvae that penetrate the alveolar wall and enter the air passages,
to be carried by mucus up bronchi and trachea, swallowed, and
leaving their host through the feces. E. rangiferi is prevalent
in reindeer in Norway (10), and scattered eggs and larvae are
common incidental findings in histological sections from lung
tissues of reindeer. Light and moderate infections are not visible
macroscopically at necropsy. However, heavy infections, as were
evident in the RDF animals, often result in firm “rubbery lungs”
that fail to collapse.
Animal R8 (RDR group) had a multifocal purulent
bacterial pneumonia when examined post mortem. Despite
this pneumonia, the chemical immobilization did not cause
particular respiratory signs in the second round, 6 days
after the first immobilization. The gross and histological
findings in the lungs indicated a subacute infection, which
might have been a result of RD and aspiration of ruminal
content (a common post-anesthetic complication) during
the first round of anesthesia. This highlights that any lung
condition alone not necessarily causes severe RD during
chemical immobilization.
Normal arterial blood oxygen saturation (at sea level)
is >95%. Hypoxemia can be defined as mild (90%−95%),
marked (75%−90%), and severe (<75%) (2, 11). For the
three RDF animals, oxygen saturation in blood (mean SpO2
70%) indicated severe hypoxemia. Also, the RDR animals
showed marked or severe hypoxemia during both rounds of
immobilization (mean SpO2 77 and 74%, respectively), as
compared to the RD– animals (mean SpO2 82 and 86%,
respectively), displaying marked but not severe hypoxemia. The
use of oxygen supplementation, which is strongly recommended
and has been established as a standard procedure (2), would
undoubtedly have reduced the hypoxemia for several of
these animals. However, due to the per-acute development
of RD and pulmonary edema, we conclude that oxygen
supplementation would not have been sufficient to save the
RDF animals.
Since these animals were immobilized at a resting state,
they were not suffering from an increased oxygen demand
associated with increased metabolic rate and body temperature,
which often is the result of stress and chasing animals
prior to darting (2). Further, none of these animals were
pregnant or in rut, which represents additional physiological
conditions in reindeer that may increase sensitivity to alpha-2
adrenoceptor agonists and contribute to side effects (2, 12). In
addition to the ambient temperature, which we have identified
as the main variable when comparing the two rounds of
immobilization, 11 of the 18 animals that were chemically
immobilized a second round showed clinical signs of infectious
keratoconjunctivitis (IKC) due to the inoculation with cervid
herpesvirus 2 (4). However, since no signs of RD were
observed during the second round of immobilization, IKC
seemed to have had little or no impact on their general
health condition.
It may be controversial to claim that high ambient
temperature was an underlying cause of mortality during
the immobilization, since there was no registered increase
in body temperature. However, the repeated immobilization
of the same animals under cooler conditions, using the
same drugs and doses for each individual, and without
experiencing the same physiological challenges, leads to
this suggestion. This further indicates that it is not only
the ambient temperature at the actual time of the chemical
immobilization that is important, but rather the hours
and maybe days prior to the immobilization. Still partly
in winter coat and experiencing a sudden high ambient
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temperature for the season, these animals were suffering from
circulatory changes, with blood shunted to the peripheral
capillary beds to contribute to loss of excess heat. This
already challenged physiological equilibrium may have been
further challenged by the adverse cardiovascular effects of
medetomidine, causing bradycardia and decrease in cardiac
output (13, 14).
It is likely that moderate to severe granulomatous interstitial
pneumonia due to E. rangiferi larvae and, for 1 animal, airway
obstruction from throat bot larvae, may have contributed to
the morbidity and mortality during chemical immobilization.
During the second round of immobilization, the RDR group
still had higher heart rate and lower SpO2 than those of
the RD– group (Table 1), indicating that RDR animals had
functional physiological characteristics that made them more
vulnerable to the drugs and doses used, independent of the
ambient temperature.
In conclusion, we believe that the main contributing factors
to the RD and hypoxemia were high ambient temperature,
circulatory collapse and lung edema, and parasite-induced
interstitial pneumonia. Although compensated for by the animal
under rest, we believe that these conditions were further
challenged by the cardiovascular effects of medetomidine.
For our study, the availability of live semidomesticated
reindeer for purchase was decisive when conducting the
immobilization in early June. However, we conclude that
chemical immobilization of reindeer with medetomidine–
ketamine should be avoided in May–June due to parasites
developing in their airways and due to the potential risk
when animals partly in winter coats encounter rising ambient
temperatures. Supplemental oxygen should be provided during
immobilization to compensate for hypoxemia in reindeer
immobilized with medetomidine–ketamine.
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